Developing a more sustainable detergent means changing its chemistry while preserving cleaning performance, storage stability and reliable dissolution.
P&G’s patent application offers a concrete example: at the same 2.21% chelant loading by weight, the ethyl gallate formulation left less capsule-film residue than the HEDP formulation in the reported test. That result connects an ingredient substitution to a practical question: will the pod dissolve reliably?
Across biodegradable polymers, cold-water enzymes and phosphonate-free chelants, P&G’s selected patents point toward a broader formulation strategy-one where compatibility between ingredients matters as much as each ingredient’s environmental profile.
P&G sustainable detergent patents and formulation strategy
P&G is protecting the compromises behind greener cleaning. A detergent still has to remove stains, survive storage and dissolve in the washing conditions consumers actually use.
Its patents address biodegradable polymers, cold-water enzymes, alternative chelants and fabric-benefit delivery. Read together, they point to a formulation strategy in which ingredient compatibility is central to performance. This article reads those complementary functions as a formulation platform, with compatibility as its organizing principle.
The strategic question is which substitutions work within an existing formula-and which create development work elsewhere. That distinction affects R&D budgets, supplier choices and the patent claims a competing product needs to navigate.
Four patent levers behind sustainable detergent chemistry
Biodegradable polymers that retain cleaning functions
EP4107205A1 lists BASF and P&G as applicants and describes alkoxylated polyamines with improved biodegradability. Its examples examine biodegradation, anti-redeposition and stain removal, including washing tests at 25°C.
Anti-redeposition means keeping removed dirt from settling back onto fabric. The challenge is to help the polymer break down after disposal while keeping it effective during washing. The patent evaluates both sides of that trade-off.
For ingredient buyers, biodegradation data is only half the brief. Ask suppliers to demonstrate soil suspension and stain removal in the intended formula, too. Biodegradable does not mean bio-based, nor does it establish lower lifecycle impact.
Cold-water enzymes with a long development history
US12338416B2 concerns fabric and home-care compositions with cold-water proteases, enzymes that break down protein-based stains. The disclosure discusses performance testing at 60°F, approximately 15.6°C, and configurations that separate protease from additional enzymes or chelant in a multi-compartment unit dose.
The family traces its earliest priority to December 2009; this US continuation was filed in November 2020 and granted on June 24, 2025. Cold-water enzyme protection is a long-running strand of P&G’s patent activity, rather than a newly emerging theme.
Lower-temperature cleaning can reduce heating demand when consumers switch from warmer cycles. The development gate is retained enzyme performance after storage, tested at the intended dose, temperature and water hardness.
Phosphonate-free chelants designed around pod performance
WO2025064739A1 describes water-soluble unit doses using alternative chelants such as alkyl gallates. The disclosure links selective metal binding to stain removal and reports improved dissolution relative to an HEDP-containing comparison. Its dissolution example uses the same 2.21% loading for HEDP and ethyl gallate.
The equal-loading comparison makes this a substitution story. It tests a change in chelant chemistry while holding loading constant. Selective iron binding is relevant to certain fruit and beverage stains; performance in hard water remains a separate test requirement.
The commercial opportunity is to replace a conventional chelant while preserving stain removal and pod reliability. Whether a competitor can use another chemistry depends on the actual claim scope and its own formulation results.
Benefit-delivery polymers at low loading
US12404479B2 covers a graft copolymer combined with a benefit agent. Reported experiments compare perfume headspace above washed fabrics and show that a low polymer loading can outperform the no-polymer comparison under those conditions.
The opportunity is to get more fabric benefit from a small amount of delivery polymer. Perfume headspace is a useful technical measure; consumer preference and the scope for reducing total dose need their own tests.
For product teams, concentration is the next development question: can improved benefit delivery support a lower overall dose while preserving cleaning and consumer acceptance?
The formulation cascade connects the patent themes
Ingredient substitutions can affect several functions at once. A different polymer may alter soil suspension and surfactant interactions. A different chelant may change metal availability and enzyme behaviour. Adjustments to water, salts or solvents can then affect viscosity, storage stability and interaction with the soluble film.
This is a formulation cascade: a local improvement can create work elsewhere. Map the affected functions first, then retest them. Some substitutions may need limited adjustment; others may require broader reformulation.
For example, replacing HEDP in a pod should trigger comparison of stain removal and film residue in the intended wash cycle. If the formula also contains enzymes, their retained activity after storage belongs in the validation plan. The chelant patent provides a concrete reason to connect chemistry and delivery tests.
The portfolio timeline shows different generations of work
The selected families span priorities from 2009 to 2023. The strongest signal is the coexistence of established enzyme work and more recent approaches to material biodegradation, chelation and benefit delivery.
| Technology | Earliest priority | Interpretation |
| Cold-water proteases | 2009 | An older family with subsequent continuation activity |
| Biodegradable polyamines | 2020 | Material design addressing biodegradation and cleaning |
| Benefit-delivery copolymers | 2022 | More recent work on delivering fabric benefits |
| Phosphonate-free unit doses | 2023 | More recent work linking chelation and dissolution |
Sources: selected patent records . Earliest priority dates distinguish the origin of an invention from later application and grant activity.
For portfolio monitoring, track distinct families by earliest priority year and flag incomplete recent years. That separates new technical directions from continued pursuit of protection around older inventions. Patent applications commonly become public around 18 months after the earliest priority date, subject to the publication rules of the relevant system. Recent-year counts can therefore understate activity still awaiting publication.
What the comparison with competitors actually shows
P&G’s selected records cover several formulation functions. Unilever and Henkel examples highlight two competitive priorities: cleaning with suitable viscosity, and preserving product appearance while changing ingredients.
| Company and evidence | Technical focus | Competitive implication |
| P&G Selected families | Biodegradation, cold-water activity, chelation and benefit delivery | Investigate potential overlap across chemistry and dosage formats |
| Unilever EP4157978B1 | Anti-redeposition polymer compositions; related disclosure addresses cleaning and viscosity | Compare soil-removal and rheology solutions under matched conditions |
| Henkel US11718816B2 | Opacified detergent without conventional polymeric opacifiers | Compare routes that preserve product appearance while changing ingredients |
Unilever’s polymer approach makes cleaning and rheology useful comparison points. Henkel’s approach targets intentional opacity without conventional polymeric opacifiers. These examples suggest different differentiation routes, not a single race to an identical formula.
Compare competitors by the functions they protect and the performance they demonstrate. A broader landscape should map verified families across each technology category, alongside licensing and supplier relationships.
Track Sustainable Detergent Innovation with Slate R&D
How are other companies approaching biodegradable ingredients, cold-water cleaning and detergent reformulation?
Slate R&D helps IP, R&D and innovation teams monitor emerging technologies, analyze patent portfolios, benchmark competitors and identify potential collaboration opportunities. Explore the wider patent landscape to put P&G’s selected inventions in context and inform your next research priorities.
Explore Sustainable Detergent Innovation
Where to investigate technical and patent white space
Three useful white-space questions concern easier substitution, alternative chemistry and different delivery formats. Each needs both technical validation and a broader patent search. Finding no relevant claim in four documents is insufficient to conclude that a route is open.
| Open question | Evidence needed before acting |
| Can a replacement work with minimal changes? | Matched formulation tests plus a search for composition and use claims |
| Can alternative chemistry achieve the same function? | Structural claim mapping and performance data for the alternative |
| Can a different delivery format reduce compatibility problems? | Format-specific claims, dissolution results and storage testing |
| Are the four inventions intended for one product? | A common formulation example or independently verified product evidence |
Start a white-space search with a performance requirement, such as reliable dissolution after storage. Then compare the molecules and formats that can deliver it against relevant claims. The most useful opportunity may be an easier integration route to the same result.
Joint ownership makes supplier diligence more important
BASF and P&G’s joint appearance on the polyamine application makes collaborative patenting a concrete supplier-strategy signal. Ingredient selection and access to application knowledge deserve to be assessed together.
Before selecting a partner, establish who can supply the material, what rights accompany purchase and who owns improvements developed during formulation work. BASF and P&G’s joint filing does not establish exclusive supply or the rights available to other customers.
The strategic opportunity for suppliers is to provide validated application knowledge alongside ingredients. For brands, partner selection should consider compatibility data, scale-up capacity and access to relevant rights together.
Environmental requirements make the test plan commercially relevant
The European Commission’s December 2025 communication on the detergent reform described a direction toward biodegradability criteria for capsule films and certain organic ingredients, alongside review of phosphorus limits. The subsequently adopted instrument is Regulation (EU) 2026/405.
These developments should not be read as a blanket 2027–2028 retailer deadline. Translate them into a product-specific evidence plan: which ingredients, delivery materials and environmental claims need testing, and by what applicable dates? Check regulatory provisions and retailer requirements separately.
Assess environmental claims at the intended dose and performance level. A phosphonate-free claim describes composition; a claim of lower overall impact requires broader evidence.
What business and technical teams should do next
Use the selected patent themes to organize decisions around demonstrated capabilities. A launch schedule should follow validated formulation, sourcing and manufacturing milestones.
| Current position | Recommended route | Evidence required |
| Core formulation works; one performance gap remains | Build internally if expertise and testing capacity are available | A defined test target, development cost and acceptance criteria |
| Gap aligns with a supplier’s established technology | Partner or investigate licensing | Supply access, relevant rights and compatibility in your formula |
| Critical capability is strategically valuable and difficult to access | Evaluate acquisition alongside partnership | Technical diligence, transferable know-how and integration economics |
| Customer demand or target claims remain uncertain | Run focused validation while monitoring patents | Buyer requirements, consumer results and a viable cost per wash |
For R&D, assess five areas: biodegradable chemistry, cold-water cleaning, chelant substitution, benefit delivery and concentrated-format compatibility. Label each “untested,” “component tested” or “validated in the target formula.” Fund the tests that close the largest integration risks.
For IP teams, map the intended formulation against relevant application and granted claims. Track composition, ingredient placement and dosage format as well as chemical structure. A molecular substitution can leave other claim questions unresolved.
For business heads, compare total cost per successful wash, validation work, supplier access and licensing terms. A higher ingredient price may be acceptable if supported by a lower dose or better performance; that trade-off needs measured evidence.
This analysis examines selected P&G patents and their implications for detergent formulation. It compares technical approaches without establishing product launch dates, overall portfolio rankings or gaps in competitors’ capabilities. The analysis is based on public patent records available as of June 2026.
Compatibility is the strategic question
These patents connect environmental substitution to the jobs the complete detergent must perform. Their strategic value lies in addressing cleaning, stability and delivery together.
The next competitive advantage may come from reducing the validation burden of reformulation: making an alternative chemistry easier to integrate without losing cleaning, stability or dissolution. That is a decision-useful target for R&D, supplier development and patent analysis alike.
Request a sustainable detergent capability assessment
Planning a sustainable fabric-care product? Request a capability assessment to identify formulation gaps, compare relevant patent families and evaluate supplier or licensing options. Access updated patent publications and prosecution developments beyond June 2026 to inform your R&D and IP decisions.
